Buy, Sell, Hold: mRNA

EP. 1: Buy, Sell, Hold: mRNA - Part 1

January 17th 2025

Jane True, Dr Andreas Kuhn, and Dr Andy Geall discuss mRNA risks, costs, effectiveness, manufacturing logistics, public messaging, and regulatory challenges.

EP. 2: Buy, Sell, Hold: mRNA - Part 2

ByChris Spivey

January 17th 2025

Jane True, Dr Andreas Kuhn, and Dr Andy Geall discuss mRNA risks, costs, effectiveness, manufacturing logistics, public messaging, and regulatory challenges.

EP. 3: Buy, Sell, Hold: mRNA - Part 3

ByChris Spivey

January 17th 2025

Jane True, Dr Andreas Kuhn, and Dr Andy Geall discuss mRNA risks, costs, effectiveness, manufacturing logistics, public messaging, and regulatory challenges.

Buy, Sell, Hold: mRNA

EP. 1: Buy, Sell, Hold: mRNA - Part 1

EP. 2: Buy, Sell, Hold: mRNA - Part 2

EP. 3: Buy, Sell, Hold: mRNA - Part 3

Trending on BioPharm International

Rentschler’s Time Capsule and How it Symbolizes European Biotech Progress

Therapeutic Nucleic Acids: Advanced Solutions for Downstream Processing & Analysis

Analytics, Automation, and Quality Driving the Next Era of Drug Development